Medicare limits coverage of Aduhelm to patients in clinical trials. The latest decision is meant to protect Alzheimer’s patients while gathering more data on whether the pricey medication actually helps slow thinking declines, agency officials said. Read more U.S. life expectancy declined again in 2021. Life spans fell for twoContinue Reading

FRIDAY, April 8, 2022 (HealthDay News) — Two-thirds of U.S. community water systems have detectable levels of uranium, and the highest levels are in Hispanic communities, according to a new study. “Previous studies have found associations between chronic uranium exposure and increased risk of hypertension, cardiovascular disease, kidney damage andContinue Reading

FRIDAY, April 8, 2022 (HealthDay News) — When implanted heart devices get infected, doctors recommend surgery to remove them, but many patients ignore that advice, a new study reveals. More than eight in 10 patients with an infected implant (such as a defibrillator or pacemaker) choose antibiotic treatment instead, thoughContinue Reading

THURSDAY, April 7, 2022 (HealthDay News) — The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progressionContinue Reading